Immutep Historical Financial Ratios
| IMMP Stock | USD 1.91 0.11 5.45% |
Immutep is lately reporting on over 122 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.06 or Days Sales Outstanding of 710 will help investors to properly organize and evaluate Immutep Ltd ADR financial condition quickly.
Immutep |
About Immutep Financial Ratios Analysis
Immutep Ltd ADRFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Immutep investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Immutep financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Immutep history.
Immutep Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Immutep Ltd ADR stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Immutep sales, a figure that is much harder to manipulate than other Immutep Ltd ADR multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Earnings Yield
The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.Net Debt To E B I T D A
A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).Most ratios from Immutep's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Immutep Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Immutep's Book Value Per Share is relatively stable compared to the past year. As of 11/27/2024, Average Payables is likely to grow to about 3.9 M, while Days Sales Outstanding is likely to drop 709.76.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 17.9K | 830.13 | 747.11 | 709.76 | PTB Ratio | 2.44 | 1.89 | 2.17 | 2.06 |
Immutep fundamentals Correlations
Click cells to compare fundamentals
Immutep Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immutep fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 8.25 | 80.32 | 1.3K | 73.47 | 66.12 | 62.81 | |
| Ptb Ratio | 1.85 | 4.23 | 2.44 | 1.89 | 2.17 | 2.06 | |
| Days Sales Outstanding | 165.36 | 578.7 | 17.9K | 830.13 | 747.11 | 709.76 | |
| Book Value Per Share | 0.078 | 0.12 | 0.11 | 0.16 | 0.14 | 0.15 | |
| Free Cash Flow Yield | (0.15) | (0.18) | (0.0569) | (0.13) | (0.14) | (0.16) | |
| Operating Cash Flow Per Share | (0.0254) | (0.0292) | (0.0356) | (0.0416) | (0.0479) | (0.0502) | |
| Stock Based Compensation To Revenue | 0.23 | 0.44 | 8.73 | 0.57 | 0.66 | 0.62 | |
| Capex To Depreciation | 0.009304 | 0.007536 | 0.0111 | 0.0228 | 0.0262 | 0.0249 | |
| Pb Ratio | 1.85 | 4.23 | 2.44 | 1.89 | 2.17 | 2.06 | |
| Ev To Sales | 5.94 | 65.48 | 889.57 | 38.61 | 44.4 | 42.18 | |
| Free Cash Flow Per Share | (0.0254) | (0.0292) | (0.0356) | (0.0417) | (0.0479) | (0.0503) | |
| Roic | (0.57) | (0.38) | (0.26) | (0.35) | (0.33) | (0.31) | |
| Net Income Per Share | (0.0315) | (0.0495) | (0.0379) | (0.0463) | (0.0532) | (0.0559) | |
| Days Of Inventory On Hand | 1.6E-5 | 81.99 | (196.05) | 3.54E-4 | 4.07E-4 | 3.87E-4 | |
| Payables Turnover | 13.71 | 1.13 | 0.72 | 0.38 | 0.44 | 0.41 | |
| Sales General And Administrative To Revenue | 0.85 | 1.63 | 42.32 | 2.48 | 2.85 | 2.7 | |
| Research And Ddevelopement To Revenue | 2.72 | 4.46 | 183.96 | 8.21 | 7.39 | 7.02 | |
| Capex To Revenue | 0.002584 | 0.004039 | 0.13 | 0.0134 | 0.0154 | 0.0146 | |
| Cash Per Share | 0.0388 | 0.0617 | 0.0995 | 0.0942 | 0.14 | 0.13 | |
| Pocfratio | (5.7) | (17.59) | (7.6) | (7.18) | (8.25) | (8.67) | |
| Capex To Operating Cash Flow | (0.001785) | (8.84E-4) | (7.58E-4) | (0.00131) | (0.001179) | (0.001238) | |
| Pfcf Ratio | (5.69) | (17.57) | (7.6) | (7.17) | (8.24) | (8.66) | |
| Days Payables Outstanding | 26.63 | 321.76 | 506.98 | 964.49 | 868.04 | 911.44 | |
| Income Quality | 0.8 | 0.59 | 0.94 | 0.9 | 0.81 | 0.54 | |
| Roe | (0.4) | (0.41) | (0.34) | (0.29) | (0.26) | (0.28) | |
| Ev To Operating Cash Flow | (4.1) | (14.34) | (5.01) | (3.77) | (4.34) | (4.56) | |
| Pe Ratio | (4.59) | (10.38) | (7.13) | (6.46) | (5.81) | (6.1) | |
| Ev To Free Cash Flow | (4.1) | (14.33) | (5.01) | (3.77) | (4.33) | (4.55) | |
| Earnings Yield | (0.22) | (0.0964) | (0.14) | (0.15) | (0.18) | (0.19) | |
| Intangibles To Total Assets | 0.33 | 0.16 | 0.1 | 0.0644 | 0.0579 | 0.055 | |
| Net Debt To E B I T D A | 1.24 | 2.77 | 2.46 | 2.85 | 2.56 | 2.69 | |
| Current Ratio | 9.26 | 12.81 | 14.16 | 13.81 | 12.43 | 7.5 | |
| Tangible Book Value Per Share | 0.0424 | 0.1 | 0.0984 | 0.15 | 0.13 | 0.14 | |
| Receivables Turnover | 2.21 | 0.63 | 0.0203 | 0.44 | 0.51 | 0.48 |
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving together with Immutep Stock
| 0.91 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.64 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Immutep Stock
| 0.78 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.62 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.6 | OPT | Opthea | PairCorr |
| 0.58 | PHVS | Pharvaris BV | PairCorr |
| 0.51 | PMVP | Pmv Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.